Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.
Indications/Uses
B-cell chronic lymphocytic leukaemia in patients w/ sufficient bone marrow reserves. 1st-line treatment in patients w/ advanced disease, Rai stages III/IV (Binet stage C) or Rai stages I/II (Binet stage A/B) where the patient has disease-related symptoms or evidence of progressive disease.
Dosage/Direction for Use
IV Adult 25 mg/m2 daily for 5 consecutive days every 28 days. Renal impairment (CrCl 30-70 mL/min) Reduce dose up to 50%.